Диссертация (1154906), страница 14
Текст из файла (страница 14)
- vol. 8(3). e59225.23. Mureddu GF, Agabiti N, Rizzello V, Forastiere F, Latini R, Cesaroni G,Masson S, Cacciatore G, Colivicchi F, Uguccioni M, Perucci CA,Boccanelli A. Prevalence of preclinical and clinical heart failure in theelderly. A population-based study in Central Italy. // Eur J Heart Fail.
–2012. - vol. 14. – p.718–729.Maggioni AP, Dahlstro ̈m U, Filippatos G,Chioncel O, Leiro MC, Drozdz J, Fruhwald F, Gullestad L, Logeart D,Fabbri G, Urso R, Metra M, Parissis J, Persson H, Ponikowski P, RauchhausM, Voors AA, Nielsen OW, Zannad F, Tavazzi L, Crespo Leiro M, DrozdzJ, Fruhwald F, Gullestad L, Logeart D, Fabbri G, Urso R, Metra M, ParissisJ, Persson H, Ponikowski P, Rauchhaus M, Voors AA, Nielsen OW, ZannadF, Tavazzi L. EURObservational Research Programme: regional differencesand 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HFPilot).
Eur J Heart Fail 2013;15:808–817.24. Pocock SJ, Ariti CA, McMurray JJV, Maggioni A, Køber L, Squire IB,Swedberg K, Dobson J, Poppe KK, Whalley GA, Doughty RN. Predictingsurvival in heart fail- ure: a risk score based on 39 372 patients from 30studies. // Eur Heart J. – 2013. - vol. 34. – p.1404 – 1413.25. Gerber Y, Weston SA, Redfield MM, Chamberlain AM, Manemann SM,Jiang R, Killian JM, Roger VL. A contemporary appraisal of the heart93failure epidemic in Olmsted County, Minnesota, 2000 to 2010. // JAMAIntern Med.
– 2015. - vol. 175. – p.996-1004.26. Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-term mechanical leftventricular assistance for end-stage heart failure. // N Engl J Med. – 2001. vol. 345(20). – p.1435–1443.27. Aronow WS. Epidemiology, pathophysiology, prognosis, and treatment ofsystolic and diastolic heart failure. // Cardiol Rev.
– 2006. vol. 14(3). –p.108-124.28. Aronow WS, Ahn C, Kronzon I. Comparison of incidences of congestiveheart failure in older African-Americans, Hispanics, and whites. // Am JCardiol. – 1999. - vol. 84(5). – p.611–612. 32.29. Sharma, S.K., Agarwal, S.K., Bhargava, K., Sharma, M., Chopra, K. &Arumugam, G. Prevalence and spectrum of iron deficiency in heart failurepatients in south Rajasthan. // Indian Heart Journal. – 2016. - vol. 68. –p.493–497.30. Abebe TB, Gebreyohannes EA, Tefera YG, Abegaz TM.
Patients withHFpEF and HFrEF have different clinical characteristics but similarprognosis: a retrospective cohort study. // BMC Cardiovasc Disord. – 2016.- vol. 16(1). – p.232.31. Yeo TJ, Yeo PS, Ching-Chiew Wong R, Ong HY, Leong KT, Jaufeerally F,et al. Iron deficiency in a multi-ethnic Asian population with and withoutheart failure: prevalence, clinical correlates, functional significance andprognosis. // Eur J Heart Fail. – 2014. - vol. 16(10). – p.1125–32.32. Enjuanes C, Klip IT, Bruguera J, Cladellas M, Ponikowski P, Banasiak W,et al. Iron deficiency and health-related quality of life in chronic heartfailure: results from a multicenter European study. // Int J Cardiol.
– 2014. vol. 174(2). – p.268–75.9433. von Haehling S, Gremmler U, Krumm M, Mibach F, Schon N, Taggeselle J,et al. Prevalence and clinical impact of iron deficiency and anaemia amongoutpatients with chronic heart failure: the PrEP Registry. // Clin Res Cardiol.– 2017. - vol. 106(6). – p.436-443.34. Kidney Disease: Improving Global Outcomes (KDIGO) Anemia WorkGroupKDIGO Clinical Practice Guideline for anemia in chronic kidneydisease.
// Kidney Int. – 2012. - vol. 2. – p.279-33535. Adams KF, Piña IL, Ghali JK, et al. Prospective evaluation of theassociation between hemoglobin concentration and quality of life in patientswith heart failure. // American Heart Journal. – 2009. - vol. 158(6).
– p.965–97136. Groenveld HF, Januzzi JL, Damman K, et al. Anemia and Mortality in HeartFailure Patients. A Systematic Review and Meta-Analysis. // Journal of theAmerican College of Cardiology. – 2008. - vol. 52(10). – p. 818–827.37. WHO criteria, HILLMAN RS,AULT KA: Hematology in clinical practice.Newyork, Mc Graw-Hill, 2002.38. Abebe TB, Gebreyohannes EA, Bhagavathula AS, Abegaz TM, Tefera YG.Anemia in severe heart failure patients: does it predict prognosis? // BMCCardiovasc Disord.
– 2017. - vol. 17(1). – p.248.39. Gorkin L, Norvell NK, Rosen RC, et al. Assessment of quality of life asobserved from the baseline data of the studies of left ventricular dysfunction(SOLVD) trial quality of life study. // Am J Cardiol. – 1993. - vol. 71. –p.1069-1073.40. Cuffe MS, Califf RM, Adams KF, Jr., et al. Short-term intravenousmilrinone for acute exacerbation of chronic heart failure: a randomizedcontrolled trial.
// JAMA. – 2002. - vol. 287. – p.1541-7.9541. Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Borenstein J.Anemia is associated with worse symptoms, greater impairment infunctional capacity and a significant increase in mortality in patients withadvanced heart failure. // Journal of the American College of Cardiology. –2002. - vol. 39(11). – p. 1780–1786.42.
Le Jemtel TH, Arain S. Mediators of anemia in chronic heart failure. // HeartFailureClinics.–2010.–vol.6(3).–p.289-293.doi:10.1016/j.hfc.2010.03.008.43. Smith GL, Lichtman JH, Bracken MB, et al. Renal impairment andoutcomes in heart failure: systematic review and meta-analysis. // J Am CollCardiol.–2006.–vol.47(10).–p.1987–1996.doi:10.1016/j.jacc.2005.11.08444. Hillege HL, Girbes AR, de Kam PJ, et al. Renal function, neurohormonalactivation, and survival in patients with chronic heart failure.
// Circulation.– 2000. - vol. 102(2). – p. 203–210.45. Go AS, Yang J, Ackerson LM, et al. Hemoglobin level, chronic kidneydisease, and the risks of death and hospitalization in adults with chronicheart failure—the anemia in chronic heart failure: Outcomes and ResourceUtilization (ANCHOR) study. // Circulation. – 2006. - 113(23)/ - p.2713–2723.46. Young JB, Abraham WT, Albert NM, et al. Relation of low hemoglobin andanemia to morbidity and mortality in patients hospitalized with heart failure(Insight from the OPTIMIZE-HF Registry). // American Journal ofCardiology.
– 2008. - vol. 101(2). – p.223–230.47. Luthi JC, Flanders WD, Burnier M, Burnand B, McClellan WM. Anemiaand chronic kidney disease are associated with poor outcomes in heartfailure patients. // BMC Nephrol. – 2006. - vol. 7. – p.3.9648. Sandhu A, Soman S, Hudson M, Besarab A. Managing anemia in patientswith chronic heart failure: what do we know? // Vascular Health and RiskManagement. – 2010. - 6(1):237–252.49. Anand IS. Pathophysiology of anemia in heart failure. Heart Failure Clinics.2010. vol.
6(3). – p.279–28850. O'Meara E, Clayton T, McEntegart MB, et al. Clinical correlates andconsequences of anemia in a broad spectrum of patients with heart failure—results of the candesartan in heart failure: assessment of reduction inmortality and morbidity (CHARM) program. // Circulation.
– 2006. - vol.113(7). – p.986–994.51. Philipp S, Ollmann H, Schink T, Dietz R, Luft F, Willenbrock R. Theimpact of anaemia and kidney function in congestive heart failure andpreserved systolic function. // Nephrology Dialysis Transplantation.
– 2005.- vol. 20(5). – p. 915–919.52. McMahon LP, Mason K, Skinner SL, Burge CM, Grigg LE, Becker GJ.Effects of haemoglobin normalization on quality of life and cardiovascularparametersinend-stagerenalfailure.//NephrologyDialysisTransplantation. – 2000. - vol. 15(9). – p.1425–1430.53. O’Meara E, Rouleau JL, White M, Roy K, Blondeau L, Ducharme A,Neagoe P-E, Sirois MG, Lavoie J, Racine N, Liszkowski M, Madore F,Tardif J-C, de Denus S, ANCHOR Investigators.
Heart failure with anemia:novel findings on the roles of renal disease, interleukins, and specific leftventricular remodeling processes. // Circ Heart Fail. - 2014. - vol. 7. – p.773-781.54. Alexander M, Grumbach K, Remy L, Rowell R, Massie BM. Congestiveheart failure hospitalizations and survival in California: patterns according torace/ethnicity. // Am Heart J.
– 1999. - vol. 137(5). – p. 919-927.9755. Silverberg DS, Wexler D, Iaina A. The role of anemia in the progression ofcongestive heart failure. Is there a place for erythropoietin and intravenousiron? // J Nephrol. – 2004. - vol. 17(6). – p.749–761.56. Silverberg DS, D W, A I. The Cardio Renal Anemia (CRA Syndrome:Congestive heart failure, Chronic Kidney Insufficiency, and Anemia. //Dialysis Times. – 2004. - vol. 10(1).
– p.1–8.57. Silverberg DS, Wexler D, Sheps D, et al. The effect of correction of mildanemia in severe, resistant congestive heart failure using subcutaneouserythropoietin and intravenous iron: a randomized controlled study. // J AmColl Cardiol. – 2001. - vol. 37(7). – p.1775–1780.58.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
